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Abstract: Flagellin component D (FlgD) is a hook capping protein involved in the proper structural assembly of bacterial flagella but is not 
present in the mature flagella. We report here the crystal structure of the truncated form of FlgD from the strain 26695 of Helicobacter pylori  
(HpFlgD_26695) in the P2 space group at 2.8 Å resolution, along with data on protein stability. The structure includes only the central 
globular part of the protein composed of conserved Fn-III and tudor domains, while the N- and C-terminal regions are absent. This structure, 
together with the tetragonal crystal structure of HpFlgD_26695 and the monoclinic crystal structure of HpFlgD_G27 reported previously, 
revealed a different mutual orientation of the two domains in the HpFlgD structures in respect to FlgD from Xanthomonas campestris and 
Pseudomonas aeruginosa. In addition, investigation of protein stability in solution showed higher protein stability then in other bacterial 
orthologues reported so far. 
 





ELICOBACTER PYLORI (H. pylori) is a small (3.5 μm × 
0.5 μm), slow growing, microaerophilic, non-spore 
forming and spiral-shaped Gram-negative rod bacterium. 
The bacterium became an important and interesting 
target of research since it is known that it can colonize 
human gastric cells and lead to development of severe 
gastrointestinal diseases such as chronic gastritis, peptic 
ulcer disease, gastric mucosa associated lymphoid tissue 
(MALT) lymphoma, and gastric cancer.[1,2] H. pylori 
flagellum is a complex structure composed of about 50 
different proteins needed for its proper regulation and 
assembly. It provides the bacterial cell a chance to move 
to a more favorable environment and to prevent 
stressful conditions.[3] Major sections that define the 
flagellum are: the filament, the hook and the basal 
body.[4] FlgD plays an important role in H. pylori 
virulence, owing to its role in forming the hook cap 
component.[5] Moreover, FlgD interacts with FliK and 
FlhB and regulates appropriate assembly of FlgE 
monomers in the hook structure.[6] Until now crystal 
structures of two other FlgD homologues, from 
Xanthomonas campestris (XcFlgD, PDB code: 3C12)[5] and 
Pseudomonas aeruginosa (PaFlgD, PDB code: 3OSV),[7] 
have been determined, as well as two crystal structures 
of H. pylori FlgD from two different strains and in two 
different space groups (HpFlgD_26695_t, tetragonal 
space group I422, and HpFlgD_G27_m, monoclinic space 
group P2, with PDB codes 4ZZF and 4ZZK, respectively).[8] 
 In this paper we describe the crystal structure of 
truncated FlgD from the H. pylori strain 26695 in a new 
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Cloning, expression and purification of 
HpFlgD_26695 
Cloning of the HP0907 gene from Helicobacter pylori 
(strain 26695, Figure 1) was performed as described in 
Pulić et al. (2016).[8] pETite C-His vector (Lucigen), bearing 
gene coding for the HpFlgD_26695 protein was trans-
formed into Escherichia coli BL21(DE3) cells by electropo-
ration on a Micropulser (BioRad). Transformed cells were 
grown on a solid Luria Bertani (LB) agar medium 
supplemented with 30 g mL−1 kanamycin. Grown colonies 
were used for protein overexpression in a 2 L LB liquid 
medium supplemented with 30 g mL−1 kanamycin at  
301 K. Protein overexpression was induced with isopropyl-
β-D-1thiogalactopyranoside (IPTG, c = 0.5 mmol L−1) when 
OD600 reached the value between 0.6–0.8. After 4 hours of 
induction the cells were harvested by centrifugation (Sigma 
6K15) at 4000 rpm and 15 min at 277 K. Harvested cells 
were resuspended in buffer (20 mmol L–1 Tris-base pH 7.5, 
150 mmol L–1 NaCl, 3 mmol L–1 phenylmethylsulfonyl 
fluoride (PMSF), 0.1 g mL−1 lysozyme, 0.05 g mL−1 DNase I, 
1 mmol L−1 MgCl2) and broken down by sonication (Vibra 
Cell, Bioblock Scientific). The soluble portion of the lysate 
was separated by centrifugation (4500 rpm, 20 min, 277 K) 
and further purified on a 1 mL HisTrap column (GE 
Healthcare) equilibrated with buffer A (20 mmol L–1 Tris-
base pH 7.5, 150 mmol L–1 NaCl). Washing step of 50 mL of 
buffer A supplemented with 20 mmol L–1 imidazole was 
performed to eliminate unspecifically bound proteins. 
Finally, elution of the protein was performed in buffer A with 
a stepwise gradient of imidazole from 20 to 500 mmol L–1. 
Size-exclusion chromatography was conducted on an 
ÄKTA Purifier (GE Healthcare) using Superdex 200 10/300 
column (GE Healthcare). Purity of the obtained fractions 
was monitored by electrophoresis under denaturating 
conditions (SDS-PAGE), and fractions with the highest 
concentration of protein were further concentrated by 
ultrafiltration in the Centricon system. 
 
Protein Crystallization and X-ray Data 
Collection 
Purified HpFlgD_26695 at a concentration of 17.5 mg mL–1 
was used in the crystallization experiment. Crystallization 
was performed by the sitting drop vapor diffusion method 
with the Oryx 8 crystallization robot (Douglas Instruments) 
using 1 L of protein mixed with 1 L precipitant solution 
and equilibrated against 75 L of the mother liquor in the 
reservoir. Monoclinic crystals of HpFlgD_26695 were 
grown from the screening solution 6 of the PACT suite 
(Qiagen) (0.1 mol L–1 SPG pH 9.0, 25 % PEG 1500) at 293 K. 
A crystal of approximate size of 0.15 × 0.05 × 0.02 mm3 was 
frozen directly in liquid nitrogen with no cryoprotectant. 
Diffraction data were collected at 100 K at the Elettra 
synchrotron, beamline XRD1, on the 2M Pilatus detector. 
360 frames at 0.5° rotation range were collected. 
Diffraction data were indexed and integrated with 
iMOSFLM,[9] and scaled with Scala[10] contained in the 
CCP4i crystallographic package.[11] 
 
Structure Solution and Refinement 
The structure of HpFlgD_26695 was solved by molecular 
replacement using AMoRe,[12] implemented in the CCP4i 
suite, with the structure of the tetragonal crystal form of 
HpFlgD_26695 (PDB entry 4ZZF) as the search model. 
Iterative model building (using Coot),[13] and refinement 
cycles (Refmac5,[14] implemented in CCP4i) were used to 
complete the structure. MolProbity[15] was used for the 
evaluation of the refinement quality. Figures of the 
protein structure were prepared with ccp4mg.[16] 
 
Figure 1. Sequence alignment of HpFlgD_26695 (HP, 
O25565_HELPY) and HpFlgD_G27 (HP, B5Z7R3_HELPG) 
using CLUSTAL OMEGA.[20] The alignment figure was 
generated using ESPript 3.0.[21] The numbering system is 
based on the HpFlgD_26695 sequence. Residues visible in 
the monoclinic crystal structures of HpFlgD_26695 and 
HpFlgD_G27 are labelled in pink while the rest of the 
sequences residues are labelled in orange. Similar residues 
in sequences are highlighted in blue, while residues of low 
or no similarity are labelled in black. Labels of the 
secondary structure elements are shown as well. Possible 
cleavage sites accessible to trypsin in both sequences are 
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To investigate stability of HpFlgD_26695 a limited 
proteolysis experiment was carried out. Each of the four 
samples of HpFlgD_26695 ( = 3 mg mL–1) in buffer A was 
digested with a selected protease (trypsin,  chymotrypsin, 
thermolysin or thrombin) in a 1 : 1000 and 1 : 500 ratio at 
298 K, and incubated for an hour. The yield of digestion 
was monitored by SDS-PAGE. The product obtained by 
trypsin digestion was further purified by size-exclusion 
chromatography (SEC) using the Superdex 200 10/300 
column (GE Healthcare). 
 The influence of the components of the crystalliza-
tion solution on the protein stability was also examined. 
HpFlgD_26695 was mixed with PEG 1500 and SPG buffer 
to reach the final values of (w / v) 25 % and 0.1 mol L–1, 
respectively, at different pH values (pH 4, pH 6–9) and left 
at room temperature (298 K). In addition, time-course 
stability experiment of protein in buffer A without any 
additives was performed to monitor the cleavage kinetics. 
Stability of the protein over time was followed by SDS-
PAGE. 
  
RESULTS AND DISCUSSION 
Crystal Structure of the Monoclinic Form 
of HpFlgD_26695 and Its Comparison 
with Other FlgD Structures 
Data collection and processing statistics of the monoclinic 
form of the HpFlgD_26695 protein (HpFlgD_26695_m) are 
given in Table 1. HpFlgD_26695_m crystallizes in the 
monclinic form, space group P2, which is a new crystal 
form in addition to the previously reported tetragonal form 
found for HpFlgD_26695 (HpFlgD_26695_t).[8] The 
structure, as was the case in the previously described 
structures (PDB codes: 4ZZK, 4ZZF),[8] is truncated with 
missing C- and N-termini (Figure 1). From the electron 
density map 146 amino acids (Asn127–Lys272) can be built. 
Statistics on the data refinement are given in Table 1. The 
overall B-factor of the monoclinic form of HpFlgD_26695 
(69.2 Å2) is slightly higher than in the previously solved 
monoclinic structure of HpFlgD_G27 (62.1 Å2). Such high 
values of B-factors are consequence of low resolution data. 
The asymmetric unit contains 4 protein molecules and  
17 water molecules. HpFlgD_26695_m occupies a Vm of  
2.64 Å3 Da–1 and has a solvent content of around 53 %. As in 
the case of the previously reported HpFlgD structures,[8] the 
monomer consists of two domains, the fibronectin domain 
III (Fn-III) and the tudor domain (Figure 2). Overlaid 
monomer structures of the two published structures, the 
monoclinic (HpFlgD_G27_m) and tetragonal (HpFlgD_26695_t) 
forms, with the present monoclinic form (HpFlgD_26695_m) 
show r.m.s.d.s. of 0.27 Å and 0.44 Å, respectively, between 
146 equivalent C atoms (Figure 3). As shown in Figure 3, 
the largest structural difference in all three superposed 
HpFlgD structures is present in the loop region positioned in 
the tudor domain (from Asp245 to Lys248). 
 As in the previously reported crystal structures of 
HpFlgD_26695_t and HpFlgD_G27_m the quaternary 
structure in HpFlgD_26695_m is a tetramer.[8] Figure 2 
 
 
Figure 2. HpFlgD_26695_m tetramer with monomer A 
shown in purple and monomer B in pink color. Beta sheets 
(9 and 12) of the two tudor domains from neighbouring 
monomers responsible for tetramerization are labelled in 
white (in monomer A) and black (in monomer B). 
 
 
Figure 3. Superposition of the monomers from the crystal 
structures of HpFlgD_26695_m_A (purple), HpFlgD_26695_t 
(gold, PDB code: 4ZZF) and HpFlgD_G27_m_A (light blue, PDB 
code: 4ZZK). ).[8] The r.m.s.d.s. for the superposition of 146 
aligned C atoms of HpFlgD_26695_t on HpFlgD_26695_m_A 
and 146 aligned C atoms of HpFlgD_G27_m_A on 
HpFlgD_26695_m_A are 0.44 Å and 0.27 Å, respectively. A 
black arrow shows the region with major structural differences 
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shows the tetramer assembly in the structure of 
HpFlgD_26695_m formed, as in the structure of 
HpFlgD_G27_m, by monomers A and B, together with 
their pair related by a two-fold symmetry axis. Monomers 
C and D form another tetramer in the same way. The two 
tudor domains of the neighbouring monomers within the 
tetramer are connected through the network of hydrogen 
bonds and salt bridges (Table 2). PISA program[17] was used 
to validate the biological assembly from the crystal 
structure packing and the analysis suggests that the 
tetramer observed in the crystal corresponds to the 
molecule in solution, as described in Pulić et al. (2016).[8] 
The largest differences in the hydrogen bond length in  
the monoclinic structures of HpFlgD_26695_m and 
HpFlgD_G27_m are found for hydrogen bonds between the 
[O2] atom of Glu265 and [O] atom of Ser241, connecting 
monomers C[–x, y, –z] and D, B and A, D[x–1, y, z–1] and C, 
with values of 0.18 Å, 0.20 Å and 0.35 Å, respectively, 
however these differences are not significant. Moreover, 
when comparing the tetragonal and monoclinic crystal 
structures of HpFlgD_26695, the hydrogen and salt bridges 
bond length differences are even greater, particularly in 
case of Glu265 [O2]···Arg252 [NH2] and Glu265 
[O2]···Ser241 [O] contacts where the range of differences 
vary between 0.69–0.88 Å and 0.40–0.59 Å, respectively. 
Dimerization of monomers D and C[–x, y, –z] through the 
12 and 9 sheets, respectively, creates the largest 
interface area that corresponds to 517 Å2 and involves 10 
hydrogen bonds and 1 salt bridge (Table 3). In the case of 
HpFlgD_G27_m the symmetrically equivalent monomers 
occupy a smaller interface area of 492.5 Å2 which is formed 
by 6 hydrogen bonds and 2 salt bridges.[18] The interface 
involved in tetramerization in the tetragonal structure of 
HpFlgD_26695 occupies the smallest interface area of  
478.8 Å2 but involves the highest number of hydrogen 
bonds and salt bridges (12 H-bonds and 2 salt bridges).[18] In 
addition to the main interface (labelled t), which is involved 
in tetramerization, the other type of interfaces (labelled  
a–c) are also present in the structure of HpFlgD_26695_m, 
but form smaller interface areas (Table 3). 
 Other bacterial orthologues of the FlgD protein, 
whose crystal structures have been solved (XcFlgD, 
PaFlgD),[5,7] show the same tendency to lose the N-
terminal part during crystallization. The HpFlgD sequence 
contains an extra 44 and 29 amino acids at the C-terminus 
in the G27 and 26695 strains, respectively in comparison 
to XcFlgD and PaFlgD. These amino acids are not present 
in the crystal structures of HpFlgD (Figure 1). 
 In all FlgD structures, the monomer is composed of 
conserved Fn-III and tudor domains. The most important 
difference is the different mutual orientation of the Fn-III 
and tudor domains in HpFlgD with respect to the same 
domains in XcFlgD and PaFlgD. When the Fn-III domain of 
PaFlgD is superposed on the same domain in 
HpFlgD_26695_m it can be seen that the tudor domains 
are not superposed but are rotated in respect to each 
other by approx. 115° (Figure 4a). The tudor domains by 
itself superimpose well in these two structures (Figure 4b). 
For more details on the description of the differences 
between the HpFlgD and its orthologues see Refs. Pulić et 
al. (2016).[8,18] 
 
Table 1. Statistics of data collection, processing and 




Crystal system  Monoclinic  
Space group  P2  
Wavelength / Å  1.000  





unit cell  8 
Z asymmetric unit 4 
Resolution range / Å 76.58–2.80 (2.95–2.80) 
Rmerge 0.113 (0.586) 
Rpim  0.108 (0.553)  
<I /σ(I)>  4.9 (1.3)  
CC half  0.988 (0.639)  
Completeness / %  94.8 (94.5)  
Redundancy  2.7 (2.7)  
Refinement 
Resolution range / Å  62.16–2.85  
Rwork / Rfree  0.227 / 0.256  
No. protein / solvent atoms  4624 / 17  
Mean B / Å2  69.2  
R.m.s.d. from ideal value 
Bond length / Å  0.011  
Bond angles / °  1.51  
Geometry 
Ramachandran favored / %  97.0  
Ramachandran outliers / %  0  
Rotamer outliers / %  2.2  
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Limited Proteolysis Studies 
Since the previously reported crystal structures of HpFlgD 
were truncated and the growth of crystals took 2 
months,[8] we wanted to test if limited proteolysis could 
eliminate the flexible regions present at the surface of the 
protein and thus speed up the crystallization process. As 
previously described, HpFlgD_26695 was cleaved with 
four proteases. Three of the four enzymes gave similar 
results enriching the pool of species at about 14 kDa, 
while thrombin did not cut the protein (Figure 5a). The 
most homogenous and discrete digestion pattern was 
obtained with trypsin and this sample was used for further 
experiments. The protein digested with trypsin was eluted 
from the SEC column at a volume of 17.11 mL (Figure 6), 
showing a reduction of molecular weight in comparison 
with the full length HpFlgD_26695.[8] A solution containing 
a monomer of about 15 kDa was obtained. The size of 
protein estimated by MALS measurement was in 
agreement with the one estimated by size exclusion 
calibration with protein standards (MW digested 
HpFlgD_26695 = 15 kDa). Analyses of HpFlgD sequences 
by Peptide cutter (http://web.expasy.org/peptide_cutter/) 
showed 2 potential cleavage sites for the trypsin protease, 
positioned at the sequence number 121 (LR|EV) and 246 
(DK|GK), Figure 1. The 3D model of the full length 
HpFlgD_26695 was built by the ITASSER software.[19] 
Investigation of the modelled and truncated structures of 
HpFlgD_26695 imply that the potential cleavage sites 
(Arg121, Lys246) are positioned in loop regions at the 
surface of the protein and could be accessible for trypsin 
cleavage (Figure 7). In those cases, cleavage would 
generate a truncated version of the protein whose size is 
compatible with the crystallized fragment. 
 Such in vitro conditions somehow reproduce a result 
similar to what occurs in the crystallization conditions, but 
they give rise to a protein fragment 2.4 kDa shorter than 
the one visible in previously described HpFlgD crystal 
structures (16.4 kDa, PDB codes: 4ZZK, 4ZZF).[8] The 
distinct processing levels encountered in the different 
experimental conditions most likely produced multiple 
oligomerization states observed in our study. Indeed, 
differently from the full length protein (that forms dimers) 
Table 2. Hydrogen bonds (Å) between monomers that are relevant for their assembly into a tetramer in the monoclinic crystal 
structure of HpFlgD_26695. * Denotes the salt bridge. 
Monomer1···Monomer2 [Symmetry code] B···A[–x, y, –z] B···A C[–x, y, –z]···D D[x–1, y, z–1]···C 
Ile264 [O]   Phe244 [N] 2.90  2.78  2.90  2.86  
Phe266 [N]   Val242 [O] 2.80  2.87  2.83  2.91  
Phe266 [O]   Val242 [N] 2.89  3.00  2.89  3.07  
Glu265 [O]   Ser241 [O] 3.51  3.40  3.33  3.52  
*Glu265 [O]   Arg252 [NH2] 2.68  2.56  2.55  2.74  
 
 
Table 3. Different types of interfaces between the monomers in the monoclinic crystal structure of HpFlgD_26695. NHB and 
NSB correspond to the number of hydrogen bonds and salt bridges, respectively. The interface type signed as t is involved in 
tetramerization. The interface areas were calculated using the PISA software.[17] 
Interface type Monomer1···Monomer2 [Symmetry code] Interface area / Å2 NHB NSB 
t  D   C[–x, y, –z]  517.0  10  1  
t  C   D[x–1, y, z–1]  491.9  8  1  
t  B   A[–x, y, –z]  481.8  8  1  
t  B   A[x, y, z]  474.1  7  1  
c  D   D[x, y–1, z]  307.7  1  3  
c  A   A[x, y–1, z]  304.6  3  5  
c  C   C[x, y–1, z]  253.3  4  5  
c  B   B[x, y–1, z]  251.2  3  5  
b  D   B[–x+1, y, –z]  267.0  3  – 
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and the crystallized species (that associate as tetramers),[8] 
such 14 kDa proteolysis product behaves as a monomer in 
solution. These results can be explained if we look at the 
tetramers observed in the crystal structures: a 14 kDa 
product can be easily obtained thanks to further 
degradation of the crystallized fragment. Indeed, if a 26 
amino acids loss occurs at the C-terminus, implying the 
removal of the last three beta strands (10–12) of the 
crystallized species. This includes the loss of -strand 12 
that is directly involved in the main interaction (12 and 9 
strands) that enables protein tetramerization (Figure 2). 
 
Stability of HpFlgD_26695 in Solution 
All flagellin components D whose crystal structures are 
known (PDB codes: 3C12, 3OSV, 4ZZK, 4ZZF) were isolated 
as full length proteins; however, in the crystal structures 
they are lacking the C- and N-termini.[5,7,8] H. pylori 
survives in the stomach environment at pH 4−6.5. The 
FlgD protein is a hook-capping protein and, similarly to 
other H. pylori flagellar proteins, is predicted to have a pI 
value of around 5. SDS-PAGE confirmed that full length 
protein left in buffer A for 3 weeks at room temperature 
was intact and no lower molecular weight degradation 
 
Figure 4. (a) Different spatial orientation of the two domains 
in HpFlgD_26695_m (gold colour) and PaFlgD (light blue color, 
PDB code: 3OSV_A). ).[7] Amino acid residues used for the 
torsion angle calculation are highlighted in dark purple and 
dark blue in HpFlgD_26695_m and PaFlgD, respectively. 
(b) Overlaied tudor domains of PaFlgD and HpFlgD_26695_m. 
The r.m.s.d. for the superposition of 43 aligned C atoms of 
PaFlgD on HpFlgD_26695_m is 2.06 Å. 
 
Figure 5. Results of the stability studies of HpFlgD_26695 
monitored by SDS-PAGE. (a) 1 – full length protein (top 
band) with initial degradation products (lower bands); 2, 3, 
4, 5 – 1 : 1000 ratio of digested HpFlgD_26695 with trypsin, 
-chymotrypsin, thermolysin and thrombin, respectively, 
and 2a, 3a, 4a, 5a – 1 : 500 ratio digested HpFlgD_26695 
with the same proteases. (b) 1 – full length protein left at 
room temperature for 3 weeks; 6 – full length protein left 
in SPG buffer pH 4. 
 
 
Figure 6. Analytical gel filtration chromatogram of the 
trypsin digested HpFlgD_26695 (green curve; MW of the 
monomer ~14 kDa) which elutes as a single peak at the 
volume of 17.11 mL corresponding to the molecular weight 
of ~15 kDa. 
 
Figure 7. Overlayed structures of the monomers of the 
HpFlgD_26695 (purple) and modeled full length 
HpFlgD_26695 (orange). Black arrows indicate possible 
positions for trypsin cleavage (Arg121, Lys246) in both 
structures and the first and last residues visible in the 
crystal structure of the monoclinic form of HpFlgD_26695 
(Asn127, Lys272). The r.m.s.d. for the superposition of 112 
C atoms of modeled full length HpFlgD_26695 on 
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products were obtained (Figure 5b). Addition of PEG 1500 
(w / v 8.5 % and 25 %) to the solution of the full length 
protein in buffer A or in the SPG buffer at pH values from 
6 to 9 did not provoke any protein degradation after 3 
weeks, as well. A lower molecular weight product at 
around 14 kDa was only observed in the sample left in the 
SPG buffer at pH 4 (Figure 5b). For XcFlgD a time-course 
auto-cleavage experiment was performed at 298K.[5] It 
was found that XcFlgD showed a tendency to degrade to 
20 kDa and 15 kDa products after 5 days, while after 10 
days the 20 kDa band disappeared and only a band at 
approximately 15 kDa remained. All these findings suggest 
that components of the mother liquor do not affect 
protein stability in the solution and that HpFlgD_26695 
shows greater stability during the 3-week period in 
comparison to its ortholog from X. campestris. It was hard 
to mimic in solution the cleavage events that happened 
during crystallization without any protease treatment. 
 
CONCLUSIONS 
HpFlgD_26695 was crystallized in a new crystal form in the 
monoclinic, P2 space group. As in the previously reported 
crystal structures of truncated HpFlgD, the protein is 
missing the N- and C-terminus portions and is composed of 
a globular region divided in the two conserved domains, Fn-
III and tudor. The main structural difference among HpFlgD 
structures occurs in the loop region (Asp245 to Lys248) of 
the tudor domain. Comparing the structure with other 
flagellin D orthologues, the most significant discrepancy is 
found in the mutual orientation of the two domains. Limited 
proteolysis experiments with trypsin showed that a protein 
fragment of a similar size as in the crystal could be obtained, 
but it probably lacks the last three -strands of the tudor 
domain and hence is unable to form the tetramer. Time-
course stability experiments produced a lower molecular 
weight (15 kDa) product only when the SPG buffer at pH 4 
was used, suggesting higher protein stability in solution 
then in other flagellin D orthologues. 
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